Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.

TSXV:THRM - Post by User

Therma Bright Inc > Very very interesting development

<< Previous

Bullboard Posts

Next >>

Comment by terr2on Dec 16, 2022 12:52pm

168 Views

Post# 35176147

RE:RE:RE:Very very interesting development

Therma Bright (THRM) has invested in inhalable statin treatments for respiratory conditions
The company signed an agreement with August Therapeutics and Ketiko Bio to acquire a 25-per-cent interest in each of InStatin and InVixa, with an option for increased ownership
InVixa and InStatin are developing inhalable statins to treat chronic and acute lung conditions, including COVID-19, asthma and COPD
Therma Bright will issue 55 million shares priced at C$0.136364 for total consideration of C$7.5 million
The parties anticipate that formal dialogue about the treatments with the FDA will begin in 2023
Therma Bright is a medical diagnostic and device technology company
Therma Bright (THRM) is down by 14.29 per cent, trading at $0.09 per share.
He is the king of dilution. Maybe you should re-read this and tell us all how full of chitt he is. YSC